Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6251–6300 of 75459
On April 15, 2025, Elizabeth Bledsoe provided her voluntary resignation as Senior Vice President & Chief People Officer of the Company.
On April 18, 2025, the Board of Directors (the “Board”) of Ramaco Resources, Inc. (the “Company”) approved the appointment of former US Senator Joseph Manchin III to serve as a member of the Board effective April 18, 2025, with a term expiring at the Company’s annual meeting of stockholders in 2025 or until his earlier death, resignation, disqualification, or removal.
On April 15, 2025, Medicine Man Technologies, Inc. (the “Company”) retained Bob Finley, a partner at FLG Partners, LLC (“FLG Partners”), a chief financial officer services and board advisory consulting firm, as the Company’s Interim Chief Financial Officer (principal financial officer and principal accounting officer).
On April 18, 2025, the Board of Directors of the Company appointed Chen Franco-Yehuda, age 41, to serve as the Company’s Chief Financial Officer, Treasurer and Secretary, effective as of May 15, 2025.
On April 18, 2025, Mr. Zvi Ben-David resigned as Chief Financial Officer, Treasurer and Secretary of DarioHealth Corp. (the “Company”), effective as of May 15, 2025.
William (Bill) Koeck, a current member of the Board of Directors (the “Board”) of Coronado Global Resources Inc. (the “Company”), notified the Board that he will not stand for reelection as a director upon expiration of his current term
On April 16, 2025, the board of directors (the “Board”) of New Jersey Resources Corporation ("NJR" or the "Company") increased the size of the Board from ten to eleven directors and unanimously elected William T. Yardley as a director, effective as of July 1, 2025.
provided the Board with notice of his intent not to stand for reelection to the Board at the 2025 Annual Meeting of Stockholders.
Mr. Harper will replace Henry F. Abbott, who previously served as Senior Vice President and Chief Credit Officer and resigned effective April 21, 2025.
On April 21, 2025, ServisFirst Bancshares, Inc. (the “Company”) announced the appointment of Jim Harper, 47, as Senior Vice President and Chief Credit Officer of ServisFirst Bank (the “Bank”), effective April 21, 2025.
On April 17, 2025, the Board of Directors (the “Board”) of Apellis Pharmaceuticals, Inc. (the “Company”), upon recommendation from the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), elected Craig A. Wheeler to the Board as a Class III director to serve until the Annual Meeting of Stockholders to be held in 2026 or until his successor has been duly elected and qualified or until his earlier death, resignation or removal.
On April 21, 2025, Farmers National Banc Corp. (the “Company” or “Farmers”), issued a press release announcing Joseph W. Sabat’s decision to retire effective May 2, 2025 as Chief Accounting Officer of the Company.
Also April 21, 2025, the Company announced the appointment of Sherry Commons as Chief Accounting Officer of the Company effective May 2, 2025, upon Mr. Sabat’s retirement.
the officers of the Company are as follows: Alan Campion, Chief Financial Officer, and Andrea Burke, Vice President.
each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof
each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof
each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof
each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof
each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof
each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof
each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof
Alan Campion, the sole director of the Purchaser immediately prior to the Effective Time, became the sole director of the Company
each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof
each of Michael T. Andriole, Mike Sherman, Martha J. Demski, Fred. A. Middleton, Robert J. Meyer, Marc D. Kozin, Pratik S. Multani, Vicki Vakiener and Lisa L. Decker resigned from his or her respective positions as a member of the Company’s board of directors and all committees thereof
the officers of the Company are as follows: Alan Campion, Chief Financial Officer, and Andrea Burke, Vice President.
The effective date of appointment of Mr. Galligan is April 22, 2025.
The effective date of appointment of Messrs. Mohamed and Burns is April 15, 2025.
The effective date of appointment of Messrs. Mohamed and Burns is April 15, 2025.
On April 15, 2025, Mr. Vecchione notified the Company’s Board of Directors of his ability to return from his temporary leave of absence and upon such notification, the Board of Directors acted to reappoint Mr. Vecchione to the offices of President and Chief Executive Officer of the Company, effective as of April 15, 2025.
Effective upon Mr. Ziegler’s resignation, Peter Vogt, the Chief Financial Officer of the Company, will serve as the Company’s principal accounting officer on an interim basis.
On April 16, 2025, Kent Ziegler, notified AXIS Capital Holdings Limited (the “Company”) of his resignation as Global Corporate Controller and principal accounting officer of the Company, effective as of the close of business on May 1, 2025 in order to pursue a new opportunity.
Dan A. Emmett, Chairman of the Board, will not stand for reelection at the 2025 annual meeting of stockholders (the “Annual Meeting”) as a result of Mr. Emmett’s decision to retire from the Board at the end of his current term.
Ray C. Leonard will not stand for reelection at the Annual Meeting as a result of Mr. Leonard’s decision to retire from the Board at the end of his current term.
elected Paul Giovacchini to the Board to fill the vacancy created by such increase, effective April 21, 2025.
On April 15, 2025, Mr. Sanford Litvack resigned from our Board of Directors, and from the Audit and Compensation Committees on which he served.
On April 18, 2025, Mr. Cook, previously our Senior Vice President and General Counsel, was appointed Chief Operating and Legal Officer of the Company.
On April 15, 2025, James W. Kupiec, M.D. informed Cassava Sciences, Inc. (the “Company”) of his intent to retire and tendered his resignation as the Company’s Chief Medical Officer, effective as of May 9, 2025.
Appointment of Chief Financial Officer On April 21, 2025, Appian Corporation (the “Company”) issued a press release announcing that Srdjan “Serge” Tanjga has been appointed Chief Financial Officer of the Company, effective May 27, 2025 (the “Effective Date”).
Mr. Tanjga succeeds Mark Lynch, who has served as the Company’s Interim Chief Financial Officer since November 2024.
On April 21, 2025, MongoDB, Inc. (the “Company”) announced that Srdjan (“Serge”) Tanjga , the Company’s Interim Chief Financial Officer, and the Company’s principal financial officer under Section 16a-1(f) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), has notified the Company of his intent to resign from his position , effective May 8, 2025.
Effective April 18, 2025, Ben Hansel resigned as a director of Totaligent, Inc. (the “Company”).
Effective April 18, 2025, the Board of Directors of the Company elected Brian Heckathorne to serve as a director.
On April 15, 2025, Ms. Stephanie Reed notified the Board of Directors (the “Board”) of Tamboran Resources Corporation (the “Company”) of her intent to resign from the Board effective immediately.
On April 15, 2025, the Company terminated Michael Jansen as the Company’s Chief Financial Officer.
On April 15, 2025, Titan Environmental Solutions Inc. (the “ Company ”) appointed Anna Skowron as the Company’s Chief Financial Officer and Secretary, effective immediately.
and as a member of the Company’s Board of Directors (the “Board”), effective April 18, 2025.
the Board appointed Robert Susman and Jacob Bauer to fill the vacancies on the Board created by the departure of each of Dr. Salzmann and Mr. Migausky
the Board appointed Robert Susman and Jacob Bauer to fill the vacancies on the Board created by the departure of each of Dr. Salzmann and Mr. Migausky
Peter Salzmann, M.D. retired from his roles as the Chief Executive Officer and principal executive officer of Immunovant, Inc. (the "Company" or "Immunovant"), effective April 20, 2025
On April 18, 2025, George Migausky, a member of Immunovant’s Board and Chair of the Audit Committee of the Board (the “Audit Committee”), resigned from the Board and the Audit Committee, effective immediately.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.